Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer.

Radiation Oncology
Adam DicklerGary J Schreiber

Abstract

A modified form of high dose rate (HDR) brachytherapy has been developed called Axxent Electronic Brachytherapy (EBT). EBT uses a kilovolt X-ray source and does not require treatment in a shielded vault or a HDR afterloader unit. A multi-center clinical study was carried out to evaluate the success of treatment delivery, safety and toxicity of EBT in patients with endometrial cancer. A total of 15 patients with stage I or II endometrial cancer were enrolled at 5 sites. Patients were treated with vaginal EBT alone or in combination with external beam radiation. The prescribed doses of EBT were successfully delivered in all 15 patients. From the first fraction through 3 months follow-up, there were 4 CTC Grade 1 adverse events and 2 CTC Grade II adverse events reported that were EBT related. The mild events reported were dysuria, vaginal dryness, mucosal atrophy, and rectal bleeding. The moderate treatment related adverse events included dysuria, and vaginal pain. No Grade III or IV adverse events were reported. The EBT system performed well and was associated with limited acute toxicities. EBT shows acute results similar to HDR brachytherapy. Additional research is needed to further assess the clinical efficacy and safety of EBT...Continue Reading

References

Jul 30, 1995·International Journal of Radiation Oncology, Biology, Physics·W R NoyesT J Kinsella
Dec 30, 1998·International Journal of Radiation Oncology, Biology, Physics·C MacLeodJ Carter
Oct 6, 2000·International Journal of Radiation Oncology, Biology, Physics·S NagG Glasgow
Jun 2, 2005·International Journal of Radiation Oncology, Biology, Physics·Astrid N ScholtenUNKNOWN PORTEC Study Group
Jan 26, 2006·JAMA : the Journal of the American Medical Association·Christopher M LeeDavid K Gaffney
Dec 5, 2006·International Journal of Radiation Oncology, Biology, Physics·Alaa FayedPerry W Grigsby
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 9, 2010·American Journal of Clinical Oncology·Vivek K MehtaThomas W Rusch

❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy
X-ray

Software Mentioned

Nucletron

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.